351 related articles for article (PubMed ID: 16265692)
1. The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern.
Dellavance A; Viana VS; Leon EP; Bonfa ES; Andrade LE; Leser PG
J Rheumatol; 2005 Nov; 32(11):2144-9. PubMed ID: 16265692
[TBL] [Abstract][Full Text] [Related]
2. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases].
Türkoğlu G; Berkem R; Karakoç AE
Mikrobiyol Bul; 2018 Oct; 52(4):413-424. PubMed ID: 30522426
[TBL] [Abstract][Full Text] [Related]
4. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
[TBL] [Abstract][Full Text] [Related]
5. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
6. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
Lee H; Kim Y; Han K; Oh EJ
Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
[TBL] [Abstract][Full Text] [Related]
7. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.
Mahler M; Hanly JG; Fritzler MJ
Autoimmun Rev; 2012 Jul; 11(9):642-5. PubMed ID: 22100330
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of dense fine speckled pattern in anti-nuclear antibody test using indirect immunofluorescence method].
Kang SY; Lee WI
Korean J Lab Med; 2009 Apr; 29(2):145-51. PubMed ID: 19411782
[TBL] [Abstract][Full Text] [Related]
9. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort.
Miyara M; Albesa R; Charuel JL; El Amri M; Fritzler MJ; Ghillani-Dalbin P; Amoura Z; Musset L; Mahler M
Clin Dev Immunol; 2013; 2013():703759. PubMed ID: 23476678
[TBL] [Abstract][Full Text] [Related]
10. Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.
Bentow C; Rosenblum R; Correia P; Karayev E; Karayev D; Williams D; Kulczycka J; Fritzler MJ; Mahler M
Lupus; 2016 Jul; 25(8):897-904. PubMed ID: 27252267
[TBL] [Abstract][Full Text] [Related]
11. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
La Jeon Y; Kang SY; Lee WI; Kim MH
Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to the lens and cornea in anti-DFS70-positive subjects.
Bizzaro N; Tonutti E; Visentini D; Alessio MG; Platzgummer S; Morozzi G; Antico A; Villalta D; Piller-Roner S; Vigevani E
Ann N Y Acad Sci; 2007 Jun; 1107():174-83. PubMed ID: 17804545
[TBL] [Abstract][Full Text] [Related]
13. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
Muro Y; Sugiura K; Morita Y; Tomita Y
Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
[TBL] [Abstract][Full Text] [Related]
14. Anti-DFS70 antibodies in 597 healthy hospital workers.
Watanabe A; Kodera M; Sugiura K; Usuda T; Tan EM; Takasaki Y; Tomita Y; Muro Y
Arthritis Rheum; 2004 Mar; 50(3):892-900. PubMed ID: 15022332
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases.
Shovman O; Gilburd B; Chayat C; Amital H; Langevitz P; Watad A; Guy A; Perez D; Azoulay D; Blank M; Segal Y; Bentow C; Mahler M; Shoenfeld Y
Clin Exp Rheumatol; 2018; 36(1):121-126. PubMed ID: 28770702
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
Seelig CA; Bauer O; Seelig HP
Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
Yumuk Z; Demir M
J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of anti-DFS70 autoantibodies.
Kang SY; Lee WI; Kim MH; La Jeon Y
Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
[TBL] [Abstract][Full Text] [Related]
19. [Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70].
Mierau R
Z Rheumatol; 2016 May; 75(4):372-80. PubMed ID: 26820723
[TBL] [Abstract][Full Text] [Related]
20. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.
Bonroy C; Schouwers S; Berth M; Stubbe M; Piette Y; Hoffman I; Devreese K; Van Hoovels L
Clin Chem Lab Med; 2018 Jun; 56(7):1090-1099. PubMed ID: 29427547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]